ABOUT THE CONFERENCE

Coronavirus disease (Covid-19) is an infectious disease caused by a newly discovered coronavirus since December, 2019 and has spread to more than 210 countries, infecting beyond 2 million people, with more than 1,37,000 fatalities. The Covid-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. People with the Covid-19virus infection will experience mild to moderate symptoms including respiratory illness. Older people and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. Most of the patients recover without requiring special treatment. No cure is available for Covid-19. Antibiotics aren’t much effective against viral infections such as Covid-19. Researchers are testing a variety of possible ways for the new drug discovery and repurposing existing drugs. The FDA has approved the antiviral drug remdesivir to treat Covid-19 in hospitalized adults and children who are of age 12 and older. The FDA has also granted an emergency use authorization (EUA) for the rheumatoid arthritis drug Baricitinib to treat Covid-19 in some cases as it works against Covid-19 by reducing inflammation and having antiviral activity. It may be used in combination with Remdesivir in people who are on mechanical ventilators or need supplemental oxygen. There is an urgent need to explore various aspects of management and treatment of this disease including vaccines development. Across the globe, two vaccines from The United States of America and two vaccines from India have received EUA for the treatment.

The prime objective of this e-conference is to provide an opportunity for the close interaction amongst scientists with varied interests, in diverse fields of the research related to Covid-19. This will also provide common online platform and more opportunities to the researchers in the areas of pharmaceutical sciences and other related areas to interact with each other. It will bring together leading formulation scientists, medicinal chemists, pharmacologists, biotechnologists, natural product scientists, regulators and other allied professionals to discuss and present the latest important developments in drug discovery and therapeutics for Covid-19 treatment. Interdisciplinary research integrates information, concepts and theories of two or more different specialized disciplines for better scientific understanding and solving the complex challenging problems associated with this disease.

The e-conference features scientific sessions which will be delivered by eminent international and national speakers from different disciplines. The e-conference will also provide the opportunity to scientists and research scholars from various organizations to put forth their innovative ideas and research findings by means of deliberations, discussions and paper presentations (oral).